Tang et al. [50] have demonstrated that PCSK9 gene interference could suppress atherosclerosis directly through decreasing vascular inflammation and inhibiting the TLR4/NF-κB signalling pathway without affecting plasma cholesterol levels in high-fat diet-fed ApoE-deficient mice. This evidence concerns the gene PCSK9 and atherosclerosis.